133 related articles for article (PubMed ID: 35027386)
21. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection.
Ma WL; Hou HA; Hsu YJ; Chen YK; Tang JL; Tsay W; Yeh PT; Yang CM; Lin CP; Tien HF
Ann Hematol; 2016 Mar; 95(4):593-601. PubMed ID: 26732884
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
Fishburne BC; Wilson DJ; Rosenbaum JT; Neuwelt EA
Arch Ophthalmol; 1997 Sep; 115(9):1152-6. PubMed ID: 9298056
[TBL] [Abstract][Full Text] [Related]
24. High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma.
Akiyama H; Takase H; Kubo F; Miki T; Yamamoto M; Tomita M; Mochizuki M; Miura O; Arai A
Cancer Sci; 2016 Oct; 107(10):1458-1464. PubMed ID: 27412324
[TBL] [Abstract][Full Text] [Related]
25. [Relapsed primary intraocular lymphoma treated with intravitreal methotrexate and high-dose chemotherapy followed by autologous stem cell rescue].
Kamio T; Yokohama A; Hayashi T; Toyama K; Koya H; Hoshino T; Saitoh T; Hanyuda N; Mukai R; Handa H; Murakami H; Tsukamoto N; Nojima Y
Rinsho Ketsueki; 2014 Feb; 55(2):244-8. PubMed ID: 24598193
[TBL] [Abstract][Full Text] [Related]
26. Retinal necrosis as the initial presentation of primary intraocular lymphoma.
Majumder PD; Raghothaman N; Kharel R; Kumar N; Khetan V
Nepal J Ophthalmol; 2017 Jan; 9(18):83-86. PubMed ID: 29022962
[TBL] [Abstract][Full Text] [Related]
27. PRESUMPTIVE RECURRENCE OF INTRAOCULAR LYMPHOMA DESPITE CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY.
Taher A; Abadir E; McCluskey P; Hamad N; Lo TH; Heydon P
Retin Cases Brief Rep; 2023 Sep; 17(5):562-566. PubMed ID: 37643043
[TBL] [Abstract][Full Text] [Related]
28. Intraocular Lymphoma Masquerading as Recurrent Iridocyclitis: Findings Based on in vivo Confocal Microscopy.
Zhang P; Tian J; Gao L
Ocul Immunol Inflamm; 2018; 26(3):362-364. PubMed ID: 29099641
[TBL] [Abstract][Full Text] [Related]
29. [Intravitreal chemotherapy for intraocular lymphoma].
Helbig H; Cerny T; de Smet MD
Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
[TBL] [Abstract][Full Text] [Related]
30. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes of intravitreal methotrexate injection protocol with a reduced initial frequency for intraocular lymphoma.
Hsu CJ; Hou HA; Lin CP; Lee YJ; Hsu WF; Yeh PT
J Formos Med Assoc; 2022 Jan; 121(1 Pt 2):416-424. PubMed ID: 34112589
[TBL] [Abstract][Full Text] [Related]
32. Serial Detection of
Choi S; Shin S; Lee ST; Lee J; Lee JS; Kim B; Lee CS
Ocul Immunol Inflamm; 2021 Apr; 29(3):485-489. PubMed ID: 32965155
[TBL] [Abstract][Full Text] [Related]
33. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
[TBL] [Abstract][Full Text] [Related]
34. Intravitreal rituximab monotherapy for management of eyes with vitreoretinal lymphoma: initial experience from India.
Rishi P; Manchegowda PT; Gondhale HP; Rishi E; Das K; Krishnakumar S; Raja T; Biswas J
Int Ophthalmol; 2021 Jul; 41(7):2495-2504. PubMed ID: 33730314
[TBL] [Abstract][Full Text] [Related]
35. Recurrence of Primary Breast Lymphoma Presenting as Bilateral Vitreoretinal Lymphoma.
Habbu K; George R; Materin M
Ocul Oncol Pathol; 2021 Oct; 7(5):311-315. PubMed ID: 34722485
[TBL] [Abstract][Full Text] [Related]
36. Highly suspected primary intraocular lymphoma in a patient with rheumatoid arthritis treated with etanercept: a case report.
Song WK; Cho AR; Yoon YH
BMC Ophthalmol; 2018 Jun; 18(1):156. PubMed ID: 29954352
[TBL] [Abstract][Full Text] [Related]
37. First observation of intraocular extranodal natural killer/T-cell lymphoma secondary to a retroperitoneal tumour: a case report and comparative review.
Chen B; Yang S; Su W
BMC Ophthalmol; 2022 Mar; 22(1):141. PubMed ID: 35346113
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
de Smet MD; Vancs VS; Kohler D; Solomon D; Chan CC
Br J Ophthalmol; 1999 Apr; 83(4):448-51. PubMed ID: 10434868
[TBL] [Abstract][Full Text] [Related]
39. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
40. Toxicity of a biodegradable microneedle implant loaded with methotrexate as a sustained release device in normal rabbit eye: a pilot study.
Palakurthi NK; Correa ZM; Augsburger JJ; Banerjee RK
J Ocul Pharmacol Ther; 2011 Apr; 27(2):151-6. PubMed ID: 21323470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
